Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296

Mid-range Performer

In 2 Starfolio Baskets

Download real time

2163.20 -5.90 (-0.27%)

61.92% Gain from 52W Low

697.6K

NSE+BSE Volume

NSE 10 Apr, 2026 3:31 PM (IST)

-

Beta 1Year

Very Low volatility

US FDA Approval

Glenmark Pharmaceuticals gets USFDA nod for progesterone vaginal inserts, with $59.2 mn in US sales See details

Glenmark Pharma RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Glenmark Pharma technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis